Startups

Senior Vice President, Late-Stage Clinical Development

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

The Senior Vice President, Late-Stage Clinical Development is one of the most visible and influential leadership roles in the company. Reporting to the Chief Medical Officer and sitting at the top of the late-stage clinical development organization, this executive plays a key role in shaping how the portfolio evolves. The person in this seat drives the future value of the company from a compound perspective. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • MD or MD/PhD, trained as a medical oncologist
  • Substantial late-stage oncology development experience, including accountability for registrational and Phase 3 programs and global regulatory filings
  • Depth in pancreatic, colorectal or lung cancer strongly preferred
  • Track record leading development teams across multiple concurrent assets
  • Demonstrated ability to build and structure a clinical development organization, including hiring program leaders and layering teams beneath them
  • Strong scientific judgment and the credibility to guide experienced development leaders
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Senior Vice President, Late-Stage Clinical Development is one of the most visible and influential leadership roles in the company. Reporting to the Chief Medical Officer and sitting at the top of the late-stage clinical development organization, this executive plays a key role in shaping how the portfolio evolves. The person in this seat drives the future value of the company from a...

Read the full posting on Revolution Medicines's site ↗

Clinical Sciences Leadership

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.